| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.3 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.3 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.3 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.3 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.045 | 0.3 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.049 | 0.3 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.3 |